Drug Shortage Report for LOVENOX
Report ID | 138198 |
Drug Identification Number | 02012472 |
Brand name | LOVENOX |
Common or Proper name | Lovenox |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ENOXAPARIN SODIUM |
Strength(s) | 30MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 10 |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2021-12-10 |
Actual start date | 2021-12-10 |
Estimated end date | 2022-01-14 |
Actual end date | 2022-01-06 |
Shortage status | Resolved |
Updated date | 2022-01-13 |
Company comments | The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.